News Archive

Date: 06/22/2012
Dr. Lisa Newman named 'Michiganian of the Year'Written by Nicole Fawcett
Date: 06/19/2012
Combining a new targeted therapy with standard chemotherapy may help defeat pancreatic cancer, according to results presented at the American Association for Cancer Research's Pancreatic Cancer: Progress and Challenges conference.
Date: 06/12/2012
Reshma Jagsi, M.D., D.Phil., associate professor at the University of Michigan Medical School, was lead author of the study that found, after taking specialty, productivity and other factors into consideration, gender disparity still exists among doctors.
Date: 06/04/2012
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59% of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
Date: 06/04/2012
Over men 1200 men with metastatic, hormone-sensitive prostate cancer were given intermittent androgen-deprivation (AD) therapy after seven months of androgen deprivation. The results show intermittent hormone therapy offers some quality-of-life benefits, but lower overall survival.
Date: 05/21/2012
Cancer survivors, their families and friends will be playing the hope card on June 3, 2012.
Date: 05/21/2012
Initial results from a first-of-its-kind international consortium of adrenal cancer researchers suggest there might be a treatment standard for patients with adrenal cancer, an extremely rare and deadly disease.
Date: 05/15/2012
Researchers found that administering a common chemotherapy drug before bone tumors took root actually fertilized the bone marrow, enabling cancer cells, once introduced, to seed and grow more easily.
Date: 05/14/2012
The May 19, 2012 Men's Fellowship Breakfast event will feature cooking demonstration, food tasting.
Date: 05/14/2012
The use of single positron emission computed tomography (SPECT)/computed tomography (CT) has been reported to change clinical management in a significant number of thyroid cancer patients, according to research presented in the May issue of The Journal of Nuclear Medicine.

Pages